News - NORD (National Organization for Rare Disorders)

September 24, 2021

TOPIC: Patients & Members, Patient Stories, Voices of Rare Cancer

Still Rare After 50 Years: Andrea’s Rare Cancer Story

Posted by Rohan Narayanan

One month after his 35th birthday, my father, Kenneth, died of leiomyosarcoma (LMS). The journey was quick. He coughed up blood and it brought him into surgery. Massachusetts General Hospital diagnosed him, and he died in another hospital closer to my hometown five months later.

As a child, I had no capacity to understand nor grieve his death. At 35, the same age he was when he passed, I began to grieve and I have not stopped. I am 55 now and I realize his… Read More

Tags: Cancer, rare cancer, rare cancer day, leiomyosarcoma, LMS, Parent, Father

September 23, 2021

TOPIC: Press Releases, Research

NORD Welcomes Aliza Fink, D.Sc. as Director of Research Programs

Posted by Rohan Narayanan

Washington, DC, September 23, 2021—The National Organization for Rare Disorders (NORD®), the leading patient advocacy organization dedicated to the identification, treatment and cure of rare diseases, announced the appointment of Aliza Fink, D.Sc. as the new Director of Research Programs. Fink, an epidemiologist by trade, brings decades of expertise and proficiency to NORD’s ongoing efforts to identify real-world research,… Read More

Tags: NORD, press release, IAMRARE, Aliza, Aliza Fink, Research Director

September 22, 2021

TOPIC: Press Releases, Research, Registries

Tatton Brown Rahman Syndrome Community and NORD® Launch Natural History Study of Tatton Brown Rahman Syndrome (TBRS)

Posted by Rohan Narayanan

Research study is open to participants worldwide to advance understanding and treatments for TBRS, a mutation of DNMT3A, causing overgrowth, autism, intellectual disabilities, orthopedic concerns, cardiac issues, and a variety of other health and developmental concerns.

Stanfordville, New York, September 21 — Tatton Brown Rahman Syndrome Community and the National Organization for Rare Disorders, Inc. today launched the largest-ever study… Read More

Tags: rare disease community, NORD, rare disease, research, registries, Registry, IAMRARE, Tatton Brown Rahman Syndrome, TBRS, TBRS Community, DNMT3A

September 17, 2021

TOPIC: Patients & Members, Advocacy, Patient Stories, Voices of Rare Cancer

A Message to Chondrosarcoma Patients: Shayna’s Rare Cancer Story

Posted by Rohan Narayanan

Shayna had advanced metastatic chondrosarcoma, and her disease progression defied many expert opinions and expectations. In 2015, Shayna was misdiagnosed with scoliosis, and nine months elapsed before she was accurately diagnosed. She was prescribed physical therapy and exercises, which were ineffective in reducing her pain. Early detection is needed in diagnosing chondrosarcoma, and we found a lack of information available about the disease.

Other false assumptions and misinformation were communicated… Read More

Tags: Cancer, advocacy, rare cancers, rare cancer, rare cancer day, Chondrosarcoma

September 15, 2021

TOPIC: Press Releases, Research, RDCA-DAP

Rare Disease Innovation and Data Sharing Accelerated by New RDCA-DAP Program

Posted by Rohan Narayanan

TUCSON, Ariz. and WASHINGTON, September 15, 2021 — The Rare Disease Cures Accelerator-Data and Analytics Platform initiative (RDCA-DAP®) officially launched its next phase on Tuesday establishing itself as the leading platform to accelerate rare disease treatment innovation. The launch was part of an all-day virtual workshop and annual meeting of rare disease stakeholders, featuring a platform demonstration, industry expert presentations… Read More

Tags: NORD, FDA, RDCA-DAP, C-Path, The Rare Disease Cures Accelerator-Data and Analytics Platform, Data

1
2
3
…
151
Next >

September 24, 2021

Still Rare After 50 Years: Andrea’s Rare Cancer Story

Posted by Rohan Narayanan

September 23, 2021

NORD Welcomes Aliza Fink, D.Sc. as Director of Research Programs

Posted by Rohan Narayanan

September 22, 2021

Tatton Brown Rahman Syndrome Community and NORD® Launch Natural History Study of Tatton Brown Rahman Syndrome (TBRS)

Posted by Rohan Narayanan

Research study is open to participants worldwide to advance understanding and treatments for TBRS, a mutation of DNMT3A, causing overgrowth, autism, intellectual disabilities, orthopedic concerns, cardiac issues, and a variety of other health and developmental concerns.

September 17, 2021

A Message to Chondrosarcoma Patients: Shayna’s Rare Cancer Story

Posted by Rohan Narayanan

September 15, 2021

Rare Disease Innovation and Data Sharing Accelerated by New RDCA-DAP Program

Posted by Rohan Narayanan

Topics

Alone we are rare. Together we are strong.®